Rand Paul’s disclosure shows his wife bought shares in COVID-19 treatment in late filing

His. Rand PaulRandal (Rand) Howard Paul Republicans are 21st Century Know-Nothing Party CDC: Unvaccinated more than twice as likely to be re-infected with COVID-19 Senate in talks to quickly pass bill on PLUS infrastructures (R-Ky.) Revealed Wednesday that his wife bought shares of Gilead Sciences, a company that makes COVID-19 treatment, in February 2020, as information about the coronavirus was just starting to come to light.

The revelation came in a disclosure from the senator’s office, filed 16 months after the 45-day deadline imposed by the Stock Act, which seeks to prevent insider trading, The Washington Post reported.

The senator’s wife, Kelley Paul, author and former communications consultant, is said to have invested between $ 1,000 and $ 15,000 in Gilead Sciences with her own funds.

This company produces the antiviral drug remdesivir, which the former President TrumpDonald Trump’s Wyoming GOP leaders say they no longer recognize Cheney as a party member GOP governors divided over response to COVID-19 outbreak Senate gives Biden big bipartisan victory MORE was given when he tested positive for COVID-19 in October.

Kelsey Cooper, director of communications for Rand Paul, told The Hill in a statement that the senator realized that the form disclosing his wife’s investment had not been submitted correctly as he prepared to file annual documents for last year.

She said he “quickly” informed the deposit office and asked for advice. The Kentucky Republican finally tabled both reports today.

She also noted that Kelley Paul made the investment “using her own income”, adding that it was “an investment she lost money on”.

The Food and Drug Administration (FDA) granted emergency use clearance for remdesivir in May after the drug showed promising results in a clinical trial. In October, the FDA gave full approval to the treatment.

The agency reversed its decision later in the month, however, advising against the drug’s use as a treatment to fight COVID-19 after a study sponsored by the World Health Organization raised concerns about its effectiveness, according to the Post.

Gilead is said to have earned $ 2.8 billion on the drug.

The drug, however, was recognized on February 24, 2020, when the deputy director general of the World Health Organization said it was the only known drug that “may have any real effectiveness” in treating the virus. , the Post reported.

The announcement was said to have taken place two days before Kelley Paul bought shares in Gilead.

On February 25, the National Institutes of Health announced they would begin a clinical trial for the drug.

Cooper told the Post that Rand Paul had not attended any briefing focused on COVID-19. Eight days after his wife invested in Gilead, he was the only senator to vote against an $ 8.3 billion emergency coronavirus bill.

Rand Paul, an ophthalmologist, was the first senator to test positive for COVID-19 in March 2020. He has repeatedly fought with the White House adviser Antoine FauciAnthony FauciOvernight Health Care: How a GOP Governor and Union Leader Changed Their Minds on COVID | DC to Require COVID-19 Vaccine or Regular Testing for City Employees | Fauci Supports Teacher Vaccination Mandates Twitter Temporarily Suspends Greene After She Says Vaccines ‘Fail’ Fauci Supports Teacher Vaccination Mandates MORE on various topics related to COVID-19, including wearing a mask and locating the origins of the virus.